Catalog Peptides Market is Set to Generate $332.1 Million Revenue By 2024: P&S Intelligence

Noida, INDIA

NEW YORK, Aug. 06, 2019 (GLOBE NEWSWIRE) -- The global catalog peptides market is expected to generate $332.1 million revenue by 2024, advancing at a CAGR of 5.8% during the forecast period. Some of the key factors driving the market growth include increasing research activities to address unmet medical needs in various therapeutic areas, growing burden of chronic diseases, and increasing investments and funding for protein-based research, according to P&S Intelligence.

On the basis of type, the catalog peptides market has been categorized into cyclic, calcitonin gene-related, caspase related, amyloid, adrenomedullin, amylin, tau, cosmetic, anti-microbial, G-protein-coupled receptor (GPCR), and others. Among these, the cyclic peptides category is projected to lead the market, both in terms of revenue and growth, throughout the analysis period. The category is expected to progress at a CAGR of 6.8% during the forecast period, mainly on account of the fact that these peptides provide good stability, high binding affinity, and selectivity toward target biomolecules.

Request to get the sample pages @

Based on application, the catalog peptides market has been categorized into commercial, academic research, and therapeutics applications. The commercial application category is further classified into antibody production, drug discovery, enzyme profiling, and others.

Among the various commercial applications of catalog peptides, the antibody production category contributed the highest share, of 52.7%, to the market in 2018. It is also expected to be the fastest growing category in the catalog peptides market during the forecast period. This can be attributed to the effectiveness of catalog peptides in raising high-quality antibodies. In addition, they provide several benefits, such as flexibility in antigen selection, low probability of cross-reactivity, and cost-effectiveness.

Browse report overview with detailed TOC on "Catalog Peptides Market Research Report: By Type (Cyclic, Calcitonin Gene-Related, Caspase Related, Amyloid, Adrenomedullin, Amylin, Tau, Cosmetic, Anti-Microbial, GPCR), Application (Commercial, Academic Research, Therapeutics), End-User, Geographical Outlook (U.S., Canada, Germany, France, U.K., Italy, Spain, China, Japan, India, South Korea, Singapore, Brazil, Mexico, Israel, South Africa, Saudi Arabia) – Global Industry Size, Share Analysis and Growth Forecast to 2024" at:

Globally, the North American catalog peptides market is expected to account for more than 30% share by 2024. This can be mainly attributed to the presence of established players, increase in the adoption of advance peptide production technologies, and rise in the investment and funding for research and development (R&D) in the region. The U.S. is expected to lead the North American catalog peptides market throughout the analysis period.

The global catalog peptides market is fragmented in nature with the presence of various players such as PolyPeptide Group, CSBio, GL Biochem (Shanghai) Ltd., CPC Scientific Inc., Auspep Pty Ltd., Peptides International Inc., Applied Biological Materials (ABM) Inc., Biomatik Corporation, Bio-Synthesis Inc., Thermo Fisher Scientific Inc., GenScript Biotech Corporation, Bachem AG, JPT Peptide Technologies GmbH, Advanced ChemTech, LifeTein LLC, Kaneka Eurogentec S.A., Elim Biopharm Inc., Creative Peptides, Abbiotec Inc., NovoPro Bioscience Inc., KareBay Biochem Inc., Ontores Biotechnologies Inc., Severn Biotech Ltd., Genway Biotech Inc., Kaneka Corporation, New England Peptide Inc., AnaSpec Inc., AAPPTec LLC, and Merck KGaA.

Make an enquiry before purchase @

Among these players, Bachem AG, Thermo Fisher Scientific Inc., Merck KGaA, and AnaSpec Inc. are the key players occupying major share in the catalog peptides market. This is mainly on the account of their large product portfolio of catalog peptides, which are being used for various applications such as antibody production, drug discovery, enzyme profiling, disease research, and biomarker discovery. Additionally, these players offer services related to customize peptides.

More Reports by P&S Intelligence

Customized Peptide Synthesis Market

North America is the largest market with an estimated contribution of 33.8% to the global customized peptide synthesis market in 2018. This growth in the North American market is mainly due to the increasing usage of peptides for drug discovery, disease research, and preparing monoclonal antibodies; increasing government funding for peptide research; and growing prevalence of chronic diseases in the region.

Dermacosmetics Market

The dermacosmetics market is classified into skincare products and haircare products. Of these, the market for skincare products is expected to hold the largest share and witness the fastest growth, contributing 88.3% revenue share to the total market by 2024. This is due to increasing prevalence of skin diseases, and availability of broad range of skincare products in the market.

About P&S Intelligence

P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.


P&S Intelligence

Toll-free: +1-888-778-7886 (USA/Canada)

International: +1-347-960-6455



Connect with us: LinkedIn | Twitter | Facebook

Blogs: |